A prospective study of inflammation markers in patients at risk of indirect acute lung injury

Shock

Volumn 17, Issue 4, 2002, Pages 252-257

  Takala, Annika ^b   Jousela, Irma ^c   Takkunen, Olli ^c   Kautiainen, Hannu ^a   Jansson, Sten Erik ^c   Orpana, Arto ^c   Karonen, Sirkka Liisa ^c   Repo, Heikki ^c  

^a RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NONE

Author keywords

ARDS; Cd11b; IL 6; IL 8; Pancreatitis; Procalcitonin; Se selectin; Sil 2r; Transfusion

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; BLOOD; BLOOD TRANSFUSION; FEMALE; HUMAN; IMMUNOLOGY; INFLAMMATION; INJURY; INTENSIVE CARE; LUNG; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; FEMALE; HUMANS; INFLAMMATION; INTENSIVE CARE; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; RECEPTORS, INTERLEUKIN-2; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0036549369     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200204000-00002     Document Type: Article

References (35)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, the Consensus Committee: The American-European Consensus Conference on ARDS. Am J Respir Crit Care Meet 149: 818-824, 1994.
2. Mantovani A, Sozzani S, Vecchi A, lntrona M, Allavena P: Cytokine activation of endothelial cells: new molecules for an old paradigm. Thromb Haemostasis 78:406-414, 1997.
3. Kroegel C, Foerster M, Häfner D, Grahmann PR, Warner JA, Braun R: Putting priming into perspective: from cellular heterogeneity to cellular plasticity. Immunol Today 21:218-222, 2000.
4. Deitch EA, Goodman ER: Prevention of multiple organ failure. Surg Clin N Am 79:1471-1488, 1999.
5. Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch C, Shealhamer JH, Parrillo JE: Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 315:547-551, 1986.
6. Donnelly SC, Stricter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643-647, 1993.
7. Rinaldo JE, Rogers RM: Adult respiratory distress syndrome: changing concepts of lung injury and repair. N Engl J Med 306:900-909, 1982.
8. Meyrick B: Pathology of the adult respiratory distress syndrome. Crit Care Clin 2:405-428, 1986.
9. Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. J Am Med Assoc 273:306-309, 1995.
10. Luhr OR, Antonsen K, Karlsson M, Aardal S, Thorsteinsson A, Frostell CG, Bonde J, the ARF Study Group: Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 159:1849-1861, 1999.
11. Rouby J-J, Puybasset L, Cluzel P, Richecoeur J, Lu Q, Grenier P, the CT Scan ARDS Study Group: Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS Severity Score. Intensive Care Med 26:1046-1056, 2000.
12. Leff JA, Bodman ME, Cho OJ, Rohrbach S, Reiss OK, Vannice JL, Repine JE: Post-insult treatment with interleukin-1 receptor antagonist decreases oxidative lung injury in rats given intratracheal interleukin-1. Am J Respir Crit Care Med 150:109-112, 1994.
13. Modelska K, Pittet JF, Folkesson HG, Courtney Broaddus V, Matthay MA: Acid-induced lung injury: protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits. Am J Respir Crit Care Med 160:1450-1456, 1999.
14. Meurer RD, Forrest MJ, Maclntyre DE: The effects of IB4 a monoclonal antibody to the CD18 leukocyte integrin on phorbol myristate acetate (PMA)-induced polymorphonuclear leukocyte (PMN) accumulation and endothelial injury in rabbit lungs. Inflammation 23:51-62, 1999.
15. Folkesson HG, Matthay MA: Inhibition of CD18 on CD11b attenuates acute lung injury after acid installation in rabbits. J Appl Physiol 82:1743-1750, 1997.
16. Vuorte J, Lindsberg P, Kaste M, Meri S, Jansson S-E, Rothlein R, Repo H: Anti-ICAM-1 monoclonal antibody R6.5 (Enlimomab) promotes activation of neutrophils in whole blood. J Immunol 162:2353-2357, 1999.
17. Hudson LD, Martin TR: Predicting ARDS: problems and prospects. Lancet 349:1783, 1997.
18. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, Umberger R, Leeper K: Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1β and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107:1062-1073, 1995.
19. Headley AS, Tolley E, Meduri GU: Infections and the inflammatory response in acute respiratory distress syndrome. Chest 111:1306-1321, 1997.
20. Baughman RP, Gunther KL, Rashkin MC, Keeton DA, Pattishall EN: Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 154:76-81, 1996.
21. Takala A, Jousela I, Jansson S-E, Olkkola KT, Takkunen O, Orpana A, Karonen S-L, Repo H: Markers of systemic inflammation predicting organ failure in community-acquired septic shock. Clin Sci 97:529-538, 1999.
22. Rubin LA, Kurman CC, Fritz ME: Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135:3127-3177, 1985.
23. Cummings CJ, Sessler CN, Beall LD, Fisher BJ, Best AM, Fowler AA, III: Soluble E-selectin levels in sepsis and critical illness: correlation with infection and hemodynamic dysfunction. Am J Respir Crit Care Med 156:431-437, 1997.
24. Hensel M, Volk T, Döcke WD, Kern F, Tschirna D, Egerer K, Konertz W, Kox WJ: Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology 89:93-104, 1998.
25. The ACCP/SCCM Consensus Conference Committee: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101:1644-1655, 1992.
26. Repo H, Jansson S-E, Leirisalo-Repo M: Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 164:193-202, 1993.
27. Amat M, Barcons M, Mancebo J, Mateo J, Oliver A, Mayoral JF, Fontcuberta J, Vila L: Evolution of leukotriene B4, peptide leukotrienes, and interleukin-8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: mortality prognostic study. Crit Care Med 28:57-62, 2000.
28. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR: Plasma and lipids from stored red blood cells cause acute lung injury in an animal model. J Clin Invest 101:1458-1467, 1998.
29. Mileski WJ, Winn RK, Vedder NB, Pohlman TH, Harlan JM, Rice CL: Inhibition of CD18-dependent neutrophil adherence reduces organ injury after hemorrhagic shock in primates. Surgery 108:206-212, 1990.
30. Botha AJ, Moore FA, Moore EE, Sauaia A, Banerjee A, Peterson VM: Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure. J Trauma 39:411-417, 1995.
31. Vedder N, Harlan J, Winn R, Maier R, Hoyt D, Moore F, Fabian T, West M, Peitzman A, Moore E, Lewis F, Malangoni M, Morris J, McNabney K, Heckbert S, Yu A, Anardi D, Peterman S: Immunomodulators: inhibitors of adhesion. Shock 13(Suppl):2, 2000.
32. Osman MO, Jensen SL: Acute pancreatitis: the pathophysiological role of cytokines and integrins. Digest Surg 16:347-362, 1999.
33. Lankisch PG, Rahlf G, Koop H: Pulmonary complications in fatal acute hemorrhagic pancreatitis. Digest Dis Sci 28:110-116, 1983.
34. Takala A, Jousela I, Olkkola KT, Jansson S-E, Leirisalo-Repo M, Takkunen O, Repo H: Systemic inflammatory response syndrome without systemic inflammation in acutely ill patients admitted to hospital in a medical emergency. Clin Sci 96:287-295, 1999.
35. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Thuy T, Whiteside T: Leukocyte activation in the peripheral blood of patients with cirrhosis: correlation with serum interleukin-6 levels and organ dysfunction. J Am Med Assoc 274: 58-65, 1995.